Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2005
05/17/2005US6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/17/2005US6894036 4-dedimethylaminotetracycline derivatives
05/17/2005US6894033 Combination therapies using vitamin B12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
05/17/2005US6894030 Treatment of DNA viral infections
05/17/2005US6893869 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering
05/17/2005US6893867 Molecular switch for regulating mammalian gene expression
05/17/2005US6893642 Anticancer nutraceutical from spirulina
05/17/2005US6893641 Ganoderma lucidum spores for treatment of autoimmune diseases
05/17/2005US6893633 Methods and compositions for promoting the maturation of monocytes
05/17/2005US6893627 Method for treating type 2 diabetes with an extract of Artemisia
05/17/2005CA2301967C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2301548C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2301543C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2250549C Reverse transcriptase inhibitor
05/17/2005CA2234409C Transferrin receptor protein of moraxella
05/17/2005CA2132374C Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
05/17/2005CA2117638C Adhesive bandages, wound dressings, sutures, drapes, orthodontic rubber bands, toothbrushes, and the like
05/17/2005CA2103845C 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines
05/12/2005WO2005042619A1 Tri-block copolymers and a process for the preparation of the same
05/12/2005WO2005042507A1 Bis {6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (4e)-4-hexenoic acid} zinc salt
05/12/2005WO2005041858A2 Mucin production inhibitor
05/12/2005WO2005023368B1 Prophylaxis of and treatment for infections from the family chlamydiaceae using amino acids as leucine or methionine
05/12/2005WO2005018531A3 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
05/12/2005WO2005009343A3 A1 adenosine receptor antogonists
05/12/2005WO2004101776A3 Novel uses of ppar modulators and professional apcs manipulated by the same
05/12/2005WO2004084926B1 Cell- and gland-restorative and/or anti-carcinogenic liquid agave extract and method of obtaining same
05/12/2005WO2004073628A3 Novel compounds
05/12/2005WO2004067560A3 Herpes simplex vp16 protein binding polypeptides
05/12/2005WO2004026899A9 Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis b and the producing method and use thereof
05/12/2005WO2004000858A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
05/12/2005WO2003070903A3 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
05/12/2005US20050101783 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide
05/12/2005US20050101781 Eponemycin and epoxomicin analogs and uses thereof
05/12/2005US20050101775 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to phosphorus; camptothecins; pharmacodynamic half-life; diagnostic imaging
05/12/2005US20050101662 Such as coumarin, dicoumarol, 7-hydroxycoumarin (umbelliferone), 6,7- dihydroxycoumarin (exculetin), 3,6,7 trihydroxycoumarin, warfarin, or warfarin sodium; cancer, Alzheimer's disease, gout, atherosclerosis, restenosis
05/12/2005US20050101651 Viricides; protease inbhibitors; useful for inhibiting the activity of picornaviral 3C proteases; for example, 6-carbamoyl-4S-{2S-[(5-naphthalen-1-yl-1H-pyrrole-2-carbonyl)-amino-3-phenyl-propionylamino}-hex-2(trans)-enoic acid ethyl ester
05/12/2005US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/12/2005US20050101635 Delivering to an external portion of the body passageway of a patient in need of a therapeutically effective amount of an antihistamine or decongestant to treat inflammatory diseases
05/12/2005US20050101632 Treating inflammation of the skin or mucous membrane by topical administration of an anti-inflammatory amount of dimethicone in the absence of any other anti-inflammatory agent
05/12/2005US20050101627 Preparation of 1H-imidazo [4,5-C] quinolin-4 amines via novel 1h-imidazo [4,5-C] quinolin-4-cyano and 1h-imidazo [4,5-C] quinolin-4-carboxamide intermediates
05/12/2005US20050101612 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
05/12/2005US20050101598 Crystal structure antibiotic; heating, dissolving, crystallization
05/12/2005US20050101588 7-Amino alkylidenyl-heterocyclic quinolones and naphthyridones
05/12/2005US20050101563 Using cyclooxygenase inhbitor and fatty acid; analgesics; antiinflammatory agents; antiarthritic agents; vision defects; urogenital disorders; gastrointestinal disorders
05/12/2005US20050101557 Immunostimulatory nucleic acid molecules
05/12/2005US20050101554 Methods for treating and preventing infectious disease
05/12/2005US20050101548 Bactericides
05/12/2005US20050101530 Cellular virus receptors and methods of use
05/12/2005US20050101529 Protein modification and maintenance molecules
05/12/2005US20050101527 Method for treating the central nervous system by administration of igf structural analogs
05/12/2005US20050100918 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100917 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100907 Method and medicament for inhibiting the expression of a given gene
05/12/2005US20050100902 5-cyano-1h-indole derivatives as antagonist of the inerleukine-8 receptors
05/12/2005US20050100894 Novel mitogen activated kinase
05/12/2005US20050100891 Identifying modulators which control endothelial cell and viral gene expression; diagnosis and treatment of cell proliferative disorders; viricides; anticancer agents
05/12/2005US20050100886 Nucleotide sequences coding dengu virus non-structural and west nile structural protein for use as tool in generating attenuated west nile viral vaccine
05/12/2005US20050100882 Viral polypeptide fusion comprising guanylyltransferase, methyltransferase and polymerase activities for use as tool in identifying modulator of viral propagation; viricides
05/12/2005US20050100610 Use of bioactive fraction from cow urine distillate ('Go-mutra'} as a bio-enhancer of anti-infective, anti-cancer agents and nutrients
05/12/2005US20050100607 administering polyethylene glycol or ethylene oxide-propylene oxide copolymers, with drugs, to improve delivery in the alimentary canal
05/12/2005US20050100563 Tin oxyfluoride or other transition metal halides in aqueous solution produce mild hydrohalo acid; topical application to affected skin and nails
05/12/2005US20050100552 Baculovirus vector, expressed in insect cells; induce apoptosis; introduced into tumor cell by viral vector, liposome, a conjugate, injection, electroporation, particle bombardment
05/12/2005US20050100540 Platelet-activating factor acetylhydrolase
05/12/2005US20050100534 firoin and firoin-A from extremophilic microorganisms ; active protection and stabilization of skin cells and their organic constituents (proteins, enzymes, membranes, nucleic acids or antioxidants); against damaging environmental influences, UV radiation.
05/12/2005CA2544377A1 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
05/12/2005CA2544281A1 Tri-block copolymers and a process for the preparation of the same
05/12/2005CA2544190A1 Inhibitors of coronavirus protease and methods of use thereof
05/12/2005CA2543763A1 Bacterial virulence factors and uses thereof
05/12/2005CA2542875A1 Method and antisense composition for selective inhibition of hiv infection in hematopoietic cells
05/12/2005CA2542776A1 Nucleoside compounds for treating viral infections
05/12/2005CA2541856A1 Modified polypeptides with therapeutic activity and methods of use
05/12/2005CA2540949A1 C-class oligonucleotide analogs with enhanced immunostimulatory potency
05/12/2005CA2539335A1 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis
05/12/2005CA2448995A1 Device and method for attracting diseased cells and foreign substances
05/11/2005EP1529845A2 Fusion glycoprotein from HCMV and HSV
05/11/2005EP1529105A1 Methods to reprogram splice site selection in pre-messenger rnas
05/11/2005EP1529054A2 Therapeutic protein and treatments
05/11/2005EP1529052A2 Lincomycin derivatives possessing antibacterial activity
05/11/2005EP1529050A1 Cephalosporins
05/11/2005EP1529049A2 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors
05/11/2005EP1529047A2 New purine derivatives
05/11/2005EP1529044A2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
05/11/2005EP1529042A1 Arylamides
05/11/2005EP1529037A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
05/11/2005EP1529032A1 Processes for the preparation of 4- 4- 4-(2 -cyanoethenyl)-2,6-dimethylphenyl )amino) -2-pyrimidinyl)amino benzonitrile
05/11/2005EP1529025A1 Polyisoprenylbenzophenone derivatives, method for production and use thereof
05/11/2005EP1528935A1 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
05/11/2005EP1528929A1 Novel use of lipopeptide preparations
05/11/2005EP1397363B1 5-ethyl-imidazotriazinones
05/11/2005EP1390399B1 Long lasting fusion peptide inhibitors for hiv infection
05/11/2005EP1326635B1 Pharmaceutical composition for immunisation against aids
05/11/2005EP1315480B1 "slow release" pharmaceutical compositions comprising lithium carbonate
05/11/2005EP1221952B1 Use of central cannabinoid receptor antagonist for preparing medicines
05/11/2005EP1214416B1 Use of replication-deficient adenoviral vector in the manufacture of a medicament to boost cd8+ t cell immune response to antigen
05/11/2005EP1165541B1 Dimeric compounds and as inhibitors of neuraminidase
05/11/2005EP1156791B1 Bupropion to treat viral diseases
05/11/2005EP1124575B1 Method for the production of an antiviral agent
05/11/2005EP0969815B1 Pharmaceutical compositions
05/11/2005EP0861071B1 Benzamidoxime prodrugs and use thereof for treating pneumonia
05/11/2005CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor
1 ... 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 ... 1798